Fairvalue-Calculator Fairvalue-Calculator
EN DE

Devyser Diagnostics AB (DVYSR) Fair Value & Analysis

Healthcare · SE · Market cap 1.5B SEK

Pricekr 84.90
Fair Valuekr 17.83
Upside-79.0%
Quality95/100
Evidence: High Range kr 10.71 – kr 25.42

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Devyser Diagnostics AB (DVYSR) currently trades at kr 84.90, while our model-based Fair Value estimate is kr 17.83 — implying the stock looks roughly 79.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa. It offers kits and reagents, such as post-transplantation, thalassemia, fetal RHD screening NIPT, Cystic fibrosis cardiovascular diseases, male infertility, rapid aneuploidy analysis, accessories, hereditary cancer, and transfusion medicine products; and Amplicon Suite and Advyser for cloud-based software solutions for data analysis and the interpretation of test results. The company was incorporated in 2004 and is headquartered in Årsta, Sweden.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Devyser Diagnostics AB (DVYSR) undervalued?
As of Jun 24, 2026, our model estimates a fair value of kr 17.83 versus a price of kr 84.90 — about −79% (overvalued). Model-based estimate, not financial advice.
What is the fair value of DVYSR?
Our 21-model fair value for Devyser Diagnostics AB is kr 17.83 (as of Jun 24, 2026), built from audited fundamentals. The current price is kr 84.90.
What is the quality score of DVYSR?
Devyser Diagnostics AB has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.